快速微生物學檢測市場規模、佔有率及成長分析（按產品、方法、應用、最終用戶和地區）－2025-2032 年產業預測

2023 年全球快速微生物檢測市場規模為 54.6 億美元，預計將從 2024 年的 59.4 億美元成長到 2032 年的 116.6 億美元，預測期內（2025-2032 年）的複合年成長率為 8.8%。

隨著都市化的加速以及由此造成的水污染，對快速微生物學檢測的需求日益成長。水污染可導致多種疾病，包括沙門氏菌感染疾病，每年在美國約有 135 萬人感染沙門氏菌。對於可以即時評估的快速生物檢測方法的需求日益明顯，無需孵化或廣泛的化驗服務。此外，全球包裝食品消費量不斷增加，例如最近 Rizo Lopez Foods 因可能受到李斯特菌污染而召回的事件，也凸顯了對快速微生物檢測方法的需求。這一趨勢凸顯了對有效的微生物檢測解決方案的需求，以增強廣泛生產過程的安全性和控制力。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管格局
• 專利分析

快速微生物學檢測市場規模（按產品和複合年成長率） (2025-2032)

• 市場概覽
• 裝置
• 試劑和套件
• 耗材

快速微生物學檢測市場規模（按方法和複合年成長率） (2025-2032)

• 市場概覽
• 基於生長的快速微生物學檢測
• 基於細胞成分的快速微生物學檢測
• 基於核酸的快速微生物檢測
• 基於可行性的快速微生物檢測

快速微生物學檢測市場規模（依應用）及複合年成長率（2025-2032）

• 市場概覽
• 臨床疾病診斷
• 食品和飲料檢驗
• 製藥和生物技術測試
• 環境測試
• 研究用途

快速微生物學檢測市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概覽
• 醫院和診斷實驗室
• 製藥和生物技術公司
• 合約研究組織（CRO）
• 學術研究所
• 食品和飲料公司

快速微生物學檢測市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Becton, Dickinson and Company（USA）
• bioMerieux SA（France）
• Danaher Corporation（USA）
• Abbott Laboratories（USA）
• Thermo Fisher Scientific Inc.（USA）
• Merck KGaA（Germany）
• Sartorius AG（Germany）
• Bruker Corporation（USA）
• QuidelOrtho Corporation（USA）
• Charles River Laboratories（USA）
• Neogen Corporation（USA）
• Don Whitley Scientific Limited（UK）
• Rapid Micro Biosystems, Inc.（USA）
• Gradientech（Sweden）
• rqmicro AG（Switzerland）
• Colifast AS（Norway）
• Serosep Limited（Ireland）
• Solus PerkinElmer（USA）
• BTNX Inc.（Canada）
• R-Biopharm AG（Germany）

結論和建議

Global Rapid Microbiology Testing Market size was valued at USD 5.46 billion in 2023 and is poised to grow from USD 5.94 billion in 2024 to USD 11.66 billion by 2032, growing at a CAGR of 8.8% during the forecast period (2025-2032).

The demand for rapid microbiology testing is escalating in response to growing urbanization and related water pollution, which contributes to various diseases, including those caused by Salmonella, responsible for approximately 1.35 million annual infections in the U.S. Current detection methods are often slow and imprecise, complicating efforts to manage water-borne illnesses. The need for swift biological analysis-capable of real-time assessment without incubation or extensive lab services-is becoming increasingly apparent. Moreover, the global rise in packaged food consumption, highlighted by recent recalls like Rizo Lopez Foods' due to potential listeriosis contamination, reinforces the necessity for prompt microbial testing methods. This trend underscores the critical need for effective microbiology solutions that enhance safety and control within diverse production processes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Rapid Microbiology Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Rapid Microbiology Testing Market Segments Analysis

Global Rapid Microbiology Testing Market is segmented by Product, Method, Application, End User and region. Based on Product, the market is segmented into Instruments, Reagents and Kits and Consumables. Based on Method, the market is segmented into Growth-Based Rapid Microbiology Testing, Cellular Component-Based Rapid Microbiology Testing, Nucleic Acid-Based Rapid Microbiology Testing and Viability-Based Rapid Microbiology Testing. Based on Application, the market is segmented into Clinical Disease Diagnostics, Food and Beverage Testing, Pharmaceutical and Biotechnology Testing, Environmental Testing and Research Applications. Based on End User, the market is segmented into Hospitals and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic and Research Institutes and Food and Beverage Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Rapid Microbiology Testing Market

The global surge in infectious diseases, particularly hospital-acquired infections (HAIs) and antibiotic resistance, has significantly heightened the demand for rapid microbiological testing. Moreover, escalating investments in healthcare, notably in developing areas, demonstrate a commitment from both governmental bodies and private entities to enhance diagnostic capabilities for effectively managing outbreaks. Additionally, the growing awareness of the importance of early diagnostic accuracy, which positively influences patient outcomes, is further driving the swift adoption of comprehensive microbiological solutions. Consequently, these factors collectively contribute to the robust growth of the global rapid microbiology testing market.

Restraints in the Global Rapid Microbiology Testing Market

Although the global rapid microbiology testing market offers numerous benefits, the high costs associated with advanced testing equipment present a significant barrier for numerous laboratories and healthcare facilities. The financial burden of acquiring sophisticated systems, coupled with ongoing expenses related to infrastructure and maintenance, particularly in low-income and underdeveloped areas, hampers widespread adoption. Additionally, smaller laboratories and hospitals often experience budget limitations, making it challenging to transition from conventional diagnostic methods to rapid microbiological testing solutions. As a result, these financial constraints negatively impact the overall growth potential of the rapid microbiological testing market.

Market Trends of the Global Rapid Microbiology Testing Market

The Global Rapid Microbiology Testing market is witnessing a significant trend towards integrating artificial intelligence (AI) and big data analytics, revolutionizing the landscape of microbial diagnostics. This innovation enables AI-driven platforms to process vast quantities of diagnostic data in real time, resulting in quicker and more precise outcomes. Furthermore, such advancements facilitate predictive assessments, which allow healthcare providers to proactively identify potential infection outbreaks and tailor their interventions accordingly. As a result, the demand for sophisticated rapid testing solutions is surging, driving growth in the market and further enhancing the efficiency of microbial detection and management in various sectors, particularly healthcare.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Rapid Microbiology Testing Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
• Reagents and Kits
• Consumables

Global Rapid Microbiology Testing Market Size by Method & CAGR (2025-2032)

• Market Overview
• Growth-Based Rapid Microbiology Testing
• Cellular Component-Based Rapid Microbiology Testing
• Nucleic Acid-Based Rapid Microbiology Testing
• Viability-Based Rapid Microbiology Testing

Global Rapid Microbiology Testing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Clinical Disease Diagnostics
• Food and Beverage Testing
• Pharmaceutical and Biotechnology Testing
• Environmental Testing
• Research Applications

Global Rapid Microbiology Testing Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Diagnostic Laboratories
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Academic and Research Institutes
• Food and Beverage Companies

Global Rapid Microbiology Testing Market Size & CAGR (2025-2032)

• North America (Product, Method, Application, End User)
  • US
  • Canada
• Europe (Product, Method, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Method, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Method, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Method, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Don Whitley Scientific Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rapid Micro Biosystems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gradientech (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• rqmicro AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colifast AS (Norway)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Serosep Limited (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Solus PerkinElmer (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BTNX Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• R-Biopharm AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations